Sorry, I don't subscribe to a buyout alternative. It may happen, but investing with buyout in mind has cost me and many other investors way too much money over the years. I trade based on other factors, and never invest/wait for a buyout. Personal choice. I believe Jim Cramer has the same point of view. YMMV
A buyout with earn-out provisions (similar to the Merck buyout deal with OncoImmune) would be disastrous for us, in my view. The bulk of the potential payout would be significantly discounted by the market.
News 
Market Data 
Discover 
